TREATMENT WITH NERIDRONATE IN ADULTS AND CHILDREN WITH OSTEOGENESIS IMPERFECTA: DATA FROM OPEN-LABEL, NOT CONTROLLED, THREE-YEAR ITALIAN STUDY

被引：0
|
作者：
Fassio, A. [1 ]
Benini, C. [1 ]
Vantaggiato, E. [1 ]
Campagnol, V. [1 ]
Giollo, A. [1 ]
Tripi, G. [1 ]
Adami, G. [1 ]
Viapiana, O. [1 ]
Rossini, M. [1 ]
Gatti, D. [1 ]
机构：
[1] Univ Verona, Dept Med, Rheumatol Sect, Verona, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P569
引用
收藏
页码：S356 / S357
页数：2
相关论文
共 50 条
  • [1] TREATMENT WITH NERIDRONATE IN CHILDREN AND ADULTS WITH OSTEOGENESIS IMPERFECTA: DATA FROM OPEN-LABEL, NOT CONTROLLED, THREE-YEAR ITALIAN STUDY
    Fassio, A.
    Idolazzi, L.
    Viapiana, O.
    Benini, C.
    Vantaggiato, E.
    Giollo, A.
    Rossini, M.
    Gatti, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 363 - 363
  • [2] Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study
    Idolazzi, L.
    Fassio, A.
    Viapiana, O.
    Rossini, M.
    Adami, G.
    Bertoldo, F.
    Antoniazzi, F.
    Gatti, D.
    BONE, 2017, 103 : 144 - 149
  • [3] Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study
    O. Viapiana
    L. Idolazzi
    A. Fassio
    G. Orsolini
    M. Rossini
    G. Adami
    F. Bertoldo
    D. Gatti
    Calcified Tissue International, 2017, 100 : 341 - 347
  • [4] Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study
    Viapiana, O.
    Idolazzi, L.
    Fassio, A.
    Orsolini, G.
    Rossini, M.
    Adami, G.
    Bertoldo, F.
    Gatti, D.
    CALCIFIED TISSUE INTERNATIONAL, 2017, 100 (04) : 341 - 347
  • [5] Intravenous neridronate in children with osteogenesis imperfecta:: A randomized controlled study
    Gatti, D
    Antoniazzi, F
    Prizzi, R
    Braga, V
    Rossini, M
    Tatò, L
    Viapiana, O
    Adami, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (05) : 758 - 763
  • [6] Setrusumab for the Treatment of Adults with Osteogenesis Imperfecta: 6-Month Data from the Open-Label Treatment Arm of the Phase 2b ASTEROID Study
    Willie, Bettina M.
    Zimmermann, Elizabeth A.
    Glorieux, Francis H.
    Hodgson, Ian
    Hall, Anthony
    MacKinnon, Alistair
    Javaid, Muhammed K.
    Shapiro, Jay
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 14 - 15
  • [7] A randomized, open-label, comparison of zoledronic acid and pamidronate treatment in children with severe osteogenesis imperfecta
    Glorieux, FH
    Plotkin, H
    Chiodo, J
    Pak, J
    Zelenakas, K
    Luchi, M
    BONE, 2005, 36 : S81 - S81
  • [8] OPEN-LABEL THERAPY STUDY IN FIVE CHILDREN WITH POMPE DISEASE: THREE-YEAR FOLLOW-UP RESULTS
    van Capelle, C. I.
    van der Beek, N. A. M. E.
    Hagemans, M. L. C.
    Arts, W. F. M.
    Hop, W. C. J.
    Lee, P.
    Jaeken, J.
    Frohn-Mulder, I. M. E.
    Merkus, P. J. F. M.
    Corzo, D.
    Puga, A. C.
    Reuser, A. J. J.
    van der Ploeg, A. T.
    CLINICAL THERAPEUTICS, 2008, 30 : S113 - S114
  • [9] Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients
    Giraud, F
    Meunier, PJ
    JOINT BONE SPINE, 2002, 69 (05) : 486 - 490
  • [10] Effect of enzyme therapy in juvenile patients with Pompe disease A three-year open-label study
    van Capelle, C. I.
    van der Beek, N. A. M. E.
    Hagemans, M. L. C.
    Arts, W. F. M.
    Hop, W. C. J.
    Lee, P.
    Jaeken, J.
    Frohn-Mulder, I. M. E.
    Merkus, P. J. F. M.
    Corzo, D.
    Puga, A. C.
    Reuser, A. J.
    van der Ploeg, A. T.
    NEUROMUSCULAR DISORDERS, 2010, 20 (12) : 775 - 782
12345